211 related articles for article (PubMed ID: 1705237)
1. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
[TBL] [Abstract][Full Text] [Related]
2. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice.
Bianchi AT; Zwart RJ; Van der Heijden PJ
Reg Immunol; 1990-1991; 3(3):131-8. PubMed ID: 2098068
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
Israf DA; Lajis NH; Somchit MN; Sulaiman MR
Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
[TBL] [Abstract][Full Text] [Related]
4. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
5. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit.
Pierre P; Denis O; Bazin H; Mbongolo Mbella E; Vaerman JP
Eur J Immunol; 1992 Dec; 22(12):3179-82. PubMed ID: 1446708
[TBL] [Abstract][Full Text] [Related]
6. Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunization.
Van der Heijden PJ; Bianchi AT; Bokhout BA; Dol M; Scholten JW; Stok W
Immunology; 1989 Mar; 66(3):404-9. PubMed ID: 2467878
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
Vadolas J; Davies JK; Wright PJ; Strugnell RA
Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
[TBL] [Abstract][Full Text] [Related]
10. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
11. Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit.
Stok W; van der Heijden PJ; Bianchi AT
Vaccine; 1994 May; 12(6):521-6. PubMed ID: 8036826
[TBL] [Abstract][Full Text] [Related]
12. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
[TBL] [Abstract][Full Text] [Related]
13. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
Lycke N
Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
[TBL] [Abstract][Full Text] [Related]
14. Immunological tools for the assessment of both humoral and cellular immune responses in Foxes (Vulpes vulpes) using ovalbumin and cholera toxin B as an antigenic model.
Rolland-Turner M; Farre G; Muller D; Rouet N; Boue F
Vaccine; 2004 Oct; 22(31-32):4163-72. PubMed ID: 15474706
[TBL] [Abstract][Full Text] [Related]
15. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
17. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
18. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
Eriksson K; Fredriksson M; Nordström I; Holmgren J
Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
[TBL] [Abstract][Full Text] [Related]
19. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.
de Geus B; Dol-Bosman M; Scholten JW; Stok W; Bianchi A
Vaccine; 1997 Jul; 15(10):1110-3. PubMed ID: 9269054
[TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
